Detalles de la búsqueda
1.
Design, synthesis, and biological evaluation of novel 8-substituted quercetin derivatives targeting the ßcatenin/B-cell lymphoma 9 interaction.
Bioorg Med Chem Lett
; 98: 129591, 2024 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38097141
2.
RORγt agonist synergizes with CTLA-4 antibody to inhibit tumor growth through inhibition of Treg cells via TGF-ß signaling in cancer.
Pharmacol Res
; 172: 105793, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34339836
3.
Discovery of Novel 1-Phenylpiperidine Urea-Containing Derivatives Inhibiting ß-Catenin/BCL9 Interaction and Exerting Antitumor Efficacy through the Activation of Antigen Presentation of cDC1 Cells.
J Med Chem
; 2024 Jun 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38912577
4.
Discovery of Novel 3-Phenylpiperidine Derivatives Targeting the ß-Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD-1 Antibody for the Treatment of Colorectal Cancer.
J Med Chem
; 66(2): 1349-1379, 2023 01 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36630177
5.
Design, synthesis and biological evaluation of quercetin derivatives as novel ß-catenin/B-cell lymphoma 9 protein-protein interaction inhibitors.
Eur J Med Chem
; 247: 115075, 2023 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36599228
6.
Microorganism, Carriers, and Immobilization Methods of the Microbial Self-Healing Cement-Based Composites: A Review.
Materials (Basel)
; 14(17)2021 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34501206
Resultados
1 -
6
de 6
1
Próxima >
>>